Genomics

Dataset Information

0

Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors


ABSTRACT: Cell-free tumour-derived DNA (ctDNA) allows non-invasive monitoring of various cancers but its utility in renal cell cancer (RCC) has not been well established. A combination of untargeted and targeted sequencing methods, applied to two independent cohorts of patients (n=90) with various renal tumour subtypes, were used to determine ctDNA content in plasma and urine. Our data revealed lower plasma ctDNA levels in RCC relative to other cancers, with untargeted detection of ~33% for both cohorts. A highly sensitive personalised approach, applied to plasma and urine from select patients (n=22), improved detection to ~50%, including in patients with early stage and even benign lesions. A machine-learning based model, applied to untargeted data, predicted this detection, potentially offering a means of triaging patient samples for personalised analysis. We observed that plasma, and for the first time, urine ctDNA may better represent tumour heterogeneity than a single tissue biopsy. Longitudinal sampling of >200 plasma samples revealed that ctDNA can track disease course. These data highlight low ctDNA levels in RCC but indicate potential clinical utility provided improvement in isolation and detection approaches.

PROVIDER: EGAS00001003530 | EGA |

REPOSITORIES: EGA

Similar Datasets

| EGAD00001005813 | EGA
2021-12-01 | GSE184904 | GEO
2010-06-25 | GSE22563 | GEO
2010-07-29 | E-GEOD-22563 | biostudies-arrayexpress
2019-12-31 | GSE118922 | GEO
| PRJNA844219 | ENA
| EGAD00001005814 | EGA
2011-07-08 | E-GEOD-30491 | biostudies-arrayexpress
2013-06-04 | E-GEOD-47077 | biostudies-arrayexpress
2023-12-18 | GSE244989 | GEO